Novartis AG (SWX:NOVN)

Novartis AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	51,721	50,317	45,440	42,206	42,781	48,659
Other Revenue	1,501	1,405	1,220	1,255	1,193	1,239
Revenue	53,222	51,722	46,660	43,461	43,974	49,898
Revenue Growth (YoY)	11.50%	10.85%	7.36%	-1.17%	-11.87%	2.51%
Cost of Revenue	12,943	12,815	12,020	11,582	11,391	15,121
Gross Profit	40,279	38,907	34,640	31,879	32,583	34,777
Selling, General & Admin	12,781	12,564	12,489	12,193	12,756	14,197
Research & Development	9,460	9,511	9,011	9,172	8,259	8,980
Other Operating Expenses	286	512	498	1,301	605	1,448
Operating Expenses	22,527	22,587	21,998	22,666	21,620	24,625
Operating Income	17,752	16,320	12,642	9,213	10,963	10,152
Interest Expense	-1,055	-1,006	-855	-800	-787	-869
Interest & Investment Income	568	568	627	377	70	91
Earnings From Equity Investments	-12	-38	-13	-11	15,337	673
Currency Exchange Gain (Loss)	-258	-258	-214	-184	-69	-135
Other Non Operating Income (Expenses)	101	61	3	-14	-29	-34
EBT Excluding Unusual Items	17,096	15,647	12,190	8,581	25,485	9,878
Merger & Restructuring Charges	-364	-364	-951	-1,267	-827	-
Gain (Loss) on Sale of Investments	-58	-45	-105	-	38	-
Gain (Loss) on Sale of Assets	33	45	225	-	724	-
Asset Writedown	-1,429	-1,428	-3,088	-	-619	-
Legal Settlements	-89	-89	542	-	-170	-
Other Unusual Items	-271	-126	310	-137	-101	-
Pretax Income	14,918	13,640	9,123	7,177	24,530	9,878
Income Tax Expense	2,058	1,701	551	1,128	1,625	1,807
Earnings From Continuing Operations	12,860	11,939	8,572	6,049	22,905	8,071
Earnings From Discontinued Operations	-	-	6,282	906	1,113	-
Net Income to Company	12,860	11,939	14,854	6,955	24,018	8,071
Minority Interest in Earnings	-1	2	-4	-	3	1
Net Income	12,859	11,941	14,850	6,955	24,021	8,072
Net Income to Common	12,859	11,941	14,850	6,955	24,021	8,072
Net Income Growth	-15.65%	-19.59%	113.52%	-71.05%	197.58%	-31.20%
Shares Outstanding (Basic)	1,999	2,018	2,077	2,181	2,243	2,277
Shares Outstanding (Diluted)	2,016	2,035	2,092	2,197	2,260	2,296
Shares Change (YoY)	-2.90%	-2.73%	-4.78%	-2.79%	-1.57%	-0.99%
EPS (Basic)	6.43	5.92	7.15	3.19	10.71	3.54
EPS (Diluted)	6.38	5.87	7.10	3.17	10.63	3.52
EPS Growth	-13.29%	-17.36%	123.90%	-70.16%	202.06%	-30.43%
Free Cash Flow	17,606	16,253	13,398	13,320	14,005	12,375
Free Cash Flow Per Share	8.73	7.99	6.40	6.06	6.20	5.39
Dividend Per Share	3.862	3.862	3.919	3.461	3.401	3.391
Dividend Growth	-1.44%	-1.44%	13.24%	1.77%	0.29%	8.68%
Gross Margin	75.68%	75.22%	74.24%	73.35%	74.10%	69.70%
Operating Margin	33.36%	31.55%	27.09%	21.20%	24.93%	20.35%
Profit Margin	24.16%	23.09%	31.83%	16.00%	54.63%	16.18%
Free Cash Flow Margin	33.08%	31.42%	28.71%	30.65%	31.85%	24.80%
EBITDA	22,086	20,662	17,518	13,940	15,633	14,932
EBITDA Margin	41.50%	39.95%	37.54%	32.07%	35.55%	29.93%
D&A For EBITDA	4,334	4,342	4,876	4,727	4,670	4,780
EBIT	17,752	16,320	12,642	9,213	10,963	10,152
EBIT Margin	33.36%	31.55%	27.09%	21.20%	24.93%	20.35%
Effective Tax Rate	13.79%	12.47%	6.04%	15.72%	6.63%	18.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.